Asian oil markets are on high alert as tensions escalate around Iran, potentially disrupting crucial crude and fuel exports ...

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

A Phase 1/2 clinical study of PD-1/IL-2 α-bia s bispecific antibody fusion protein (IBI363) in the treatment of advanced "cold" tumor subtypes (acral and mucosal) malignant melanoma. The data ...

This study confirms that TEV-56278 targets IL-2 activity to PD-1 expressing T cells within the tumor microenvironment and induces strong immune response, thereby promoting anti-tumor activity.

The purpose of this study is to develop a TIL cell therapy product (HS-IT101) that requires low-dose lymphodepletion and IL-2 infusion to reduce safety risks and to improve clinical accessibility.

Interleukin-2 (IL-2) is a pivotal cytokine that plays a crucial role in the activation, proliferation, and functional regulation of multiple immune cells. High-dose IL-2 has been approved for ...

Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study ...

A couple of University of Illinois Big Ten golfers of the year return to the Memorial Health Championship. Who are some other ...

The Korn Ferry Tour pro golf tournament is back in Springfield this week, and general admission is free. Here's what else to ...

Starting at 4 a.m. Wednesday, there will be a lane reduction on southbound Towanda Avenue between Raab Road and the bridge ...

It's been more than a year since Heritage Behavioral Health Center was given a new building by Sally Andreas. The building, located at 2800 N. Water ...

Scandinavian Airlines (SAS) CEO Anko van der Werff is expressing interest in additional Airbus A321LRs as the carrier reports good operational performance. “If the price-points were good, both ...